This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Ponugupati Suresh Kumar: Innovator in Antiviral Compounds
Introduction
Ponugupati Suresh Kumar is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of antiviral research, particularly in the development of compounds that target the Hepatitis C virus.
Latest Patents
Kumar holds a patent for his work on Hepatitis C virus inhibitors. This patent focuses on antiviral compounds and specifically addresses combinations of compounds that inhibit the function of the NS5A protein encoded by the Hepatitis C virus (HCV). The patent outlines compositions comprising these combinations and methods for effectively inhibiting the NS5A protein's function.
Career Highlights
Kumar is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research in antiviral therapies. His work has the potential to impact the treatment of Hepatitis C, a virus that affects millions worldwide.
Collaborations
Throughout his career, Kumar has collaborated with esteemed colleagues, including Piyasena Hewawasam and John F Kadow. These collaborations have further enriched his research and contributed to the development of innovative antiviral solutions.
Conclusion
Ponugupati Suresh Kumar's contributions to antiviral research, particularly in the area of Hepatitis C, highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile